efavirenz and betadex
efavirenz has been researched along with betadex in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Babu, RJ; Chadha, G; Fasina, O; Lee, YH; Parsons, DL; Rangari, VK; Sathigari, S; Wright, N | 1 |
| Rao, MRP; Shirsath, C | 1 |
| Ângelos, MA; da Silva, RMF; de Freitas Neto, JL; de Melo, CG; do Nascimento Gomes Barbosa, I; Dos Santos Mendes, LM; Ferreira, MRA; Neto, PJR; Rolim, LA; Soares, LAL | 1 |
Other Studies
3 other study(ies) available for efavirenz and betadex
| Article | Year |
|---|---|
Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alkynes; Benzoxazines; beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cyclopropanes; Drug Carriers; Drug Compounding; Drug Stability; Freeze Drying; HIV Protease Inhibitors; Kinetics; Microscopy, Electron, Scanning; Solubility; Technology, Pharmaceutical | 2009 |
Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
Topics: Alkynes; Animals; Benzoxazines; beta-Cyclodextrins; Biological Availability; Cyclopropanes; Models, Molecular; Nanostructures; Rats; Reverse Transcriptase Inhibitors; Solubility | 2017 |
Development of Pediatric Orodispersible Tablets Based on Efavirenz as a New Therapeutic Alternative.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Alkynes; Benzoxazines; beta-Cyclodextrins; Calorimetry, Differential Scanning; Cyclopropanes; Drug Compounding; Hardness; Humans; Pediatrics; Reverse Transcriptase Inhibitors; Solubility; Tablets | 2020 |